Solriamfetol hydrochloride

Solriamfetol Hydrochloride is a medication mainly used to improve wakefulness in adults with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (OSA). It works by targeting dopamine and norepinephrine reuptake, stimulating the central nervous system to promote alertness. Unlike some traditional stimulants, it has a relatively low potential for abuse and is generally well-tolerated, though it may cause side effects like headache, nausea, or increased blood pressure. It is not a treatment for the underlying causes of OSA and should be used alongside appropriate primary therapies like CPAP. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Sunosi (TN) and [(2R)-2-amino-3-phenylpropyl] carbamate;hydrochloride. It is listed as a controlled drug substance (Schedule IV). Its PubChem CID is 67583702.